Clinical trial
A Study to Assess Two Different Strategies of Combining Dexamethasone and…
NCT00063791 · Millennium Pharmaceuticals, Inc., Industry · No longer available
Key facts
| NCT number | NCT00063791 |
|---|---|
| Title | A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE |
| Official title | An Open-Labeled, Randomized Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE in Patients With Relapsed Multiple Myeloma Who Have Failed Four or More Lines of Therapy |
| Lead sponsor | Millennium Pharmaceuticals, Inc., Industry |
| Status | No longer available |
| Study type | Expanded Access |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Bortezomib |
| First posted | Jul 8, 2003 |
| Last update posted | Feb 14, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: